A critical role for HER3 in HER2-amplified and non-amplified breast cancers: function of a kinase-dead RTK.
about
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1)Precision medicine in breast cancer: reality or utopia?Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121).HER-3 targeting alters the dimerization pattern of ErbB protein family members in breast carcinomas.Anti-tumor efficacy of BEZ235 is complemented by its anti-angiogenic effects via downregulation of PI3K-mTOR-HIF1alpha signaling in HER2-defined breast cancers.Rationally Repurposing Ruxolitinib (Jakafi (®)) as a Solid Tumor TherapeuticCaloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer.Targeted therapies in breast cancer: New challenges to fight against resistance.Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma.A Metabolomic Approach to Predict Breast Cancer Behavior and Chemotherapy Response.Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancerPosttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer
P2860
Q26773907-CAC01655-19A1-431D-872C-1CF443E83DA2Q33772914-82386F53-198E-4F2A-8103-8B53FA64DB8EQ33809114-E9EA71B0-2A25-4892-9DC9-EC10E2CE83F0Q33917876-6F843453-DD15-4FB9-9547-33B83DA6718CQ34506951-B4893B62-B9B7-4030-B58B-34D66EF3E189Q36879470-69B9BDF0-F101-4F84-8AF5-D052C23B63F0Q36995729-E2A2A3F2-59A1-4B2B-A6B8-817EEB294A19Q37216944-0E60048A-133B-4CFB-B01A-5964EB50E8F2Q37743048-3D8023B2-FC64-43F9-ABC7-9A6CC2435384Q38935156-38A8F5B9-3C45-4629-80F2-89F755FB8227Q47150730-C09230CF-A92A-4BE9-AF4E-CD731E5C57EDQ52692110-528C4A64-16DC-43D4-9FDF-8CE8943F6B82Q58112887-C0AD2403-D560-4FE1-89E9-7848982E6428Q58803127-49C64888-CCEE-447A-A6D4-B1E4EDF776AD
P2860
A critical role for HER3 in HER2-amplified and non-amplified breast cancers: function of a kinase-dead RTK.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A critical role for HER3 in HE ...... function of a kinase-dead RTK.
@ast
A critical role for HER3 in HE ...... function of a kinase-dead RTK.
@en
type
label
A critical role for HER3 in HE ...... function of a kinase-dead RTK.
@ast
A critical role for HER3 in HE ...... function of a kinase-dead RTK.
@en
prefLabel
A critical role for HER3 in HE ...... function of a kinase-dead RTK.
@ast
A critical role for HER3 in HE ...... function of a kinase-dead RTK.
@en
P2093
P2860
P1476
A critical role for HER3 in HE ...... function of a kinase-dead RTK.
@en
P2093
Brain Leyland-Jones
Casey Williams
Nandini Dey
P2860
P304
P407
P577
2015-04-15T00:00:00Z